共 146 条
[1]
Glynne-Jones R(2017)Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 28 iv22-iv40
[2]
Wyrwicz L(2018)Rectal Cancer, version 2.2018, NCCN clinical practice guidelines in oncology J Natl Compr Cancer Netw 16 874-901
[3]
Tiret E(2004)Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731-1740
[4]
Benson AB(2014)Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and bowel project trial R-04 J Clin Oncol 32 1927-1934
[5]
Venook AP(2012)Neoadjuvant treatment response as an early response indicator for patients with rectal cancer J Clin Oncol 30 1770-1776
[6]
Al-Hawary MM(2014)Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial J Clin Oncol 32 1554-1562
[7]
Sauer R(2011)Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience J Clin Oncol 29 3753-3760
[8]
Becker H(2011)Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer Ann Surg 254 486-492
[9]
Hohenberger W(2008)Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients Int J Radiat Oncol Biol Phys 72 99-107
[10]
O'Connell MJ(2004)Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results Ann Surg 240 711-717